Genelex

Genelex has been a leader in molecular diagnostics and genetic testing for more than 30 years. Founded in 1987, Genelex is a highly accredited leader in precision medication management and one of the first clinical laboratories to provide pharmacogenetic testing and interpretation as the creator of YouScript - a patented, proprietary, and powerful clinical decision support tool. More than 90% of the population have genetic variations that determine how their bodies process drugs, including prescription and over-the-counter medications, leading to diverse responses to the same medication dosage. Annually, the United States witnesses 8.6 million dangerous adverse drug events, causing over 100,000 deaths, with the FDA estimating the cost at a minimum of $30 billion per year. Genelex's expert staff and state-of-the-art laboratory are focused on preventing drug-gene and drug-drug interactions, especially in patients with significant polypharmacy who are at most risk. As one of the longest-running leaders in pharmacogenetics, Genelex is committed to helping polypharmacy patients and physicians improve medication outcomes with pharmacogenetic testing. The company offers both clinical and research-level PGx testing to CROs and pharmaceutical companies to ensure safer drugs to market. Genelex envisions making pharmacogenetics a commonplace term in every physician's office and kitchen table across the United States.